Assembly Historical Financial Ratios

ASMB Stock

USD 10.80 0.10 0.92%

Assembly Biosciences is presently reporting on over 107 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 2.7 or Days Sales Outstanding of 2.39 will help investors to properly organize and evaluate Assembly Biosciences financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.

About Assembly Financial Ratios Analysis

Assembly BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Assembly Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Assembly financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Assembly Biosciences history.

Assembly Biosciences Financial Ratios Chart

At present, Assembly Biosciences' Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 100.24, whereas Price To Sales Ratio is forecasted to decline to 3.16.

Price To Sales Ratio Days Sales Outstanding Average Payables Ev To Sales

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Assembly Biosciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Assembly Biosciences sales, a figure that is much harder to manipulate than other Assembly Biosciences multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Most ratios from Assembly Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Assembly Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Assembly Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.At present, Assembly Biosciences' Book Value Per Share is projected to increase significantly based on the last few years of reporting. The current year's Payables Turnover is expected to grow to 100.24, whereas Price To Sales Ratio is forecasted to decline to 3.16.

	2021	2022	2025 (projected)
Interest Debt Per Share	0.14	0.86	0.49
Revenue Per Share	0.13	1.56	4.99

Interest Debt Per Share Revenue Per Share

Assembly Biosciences fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.48	0.98	-0.25	0.36	-0.15	-0.44	0.24	0.48	1.0	-0.15	0.08	-0.46	-0.18	0.61	-0.6	0.73	0.09	-0.58	0.24	0.32	0.27	0.24	0.39	-0.22	0.42
Ptb Ratio	0.48		0.52	0.25	0.28	0.36	0.28	0.11	1.0	0.48	0.36	0.14	-0.28	0.34	0.38	-0.27	0.47	0.01	-0.27	0.8	-0.22	0.8	0.8	-0.03	-0.31	0.11
Days Sales Outstanding	0.98	0.52		-0.23	0.39	-0.12	-0.38	0.23	0.52	0.98	-0.12	0.13	-0.48	-0.15	0.64	-0.62	0.77	0.07	-0.6	0.21	0.3	0.24	0.22	0.37	-0.2	0.46
Book Value Per Share	-0.25	0.25	-0.23		-0.08	0.82	0.66	0.13	0.25	-0.25	0.82	-0.41	0.06	0.93	-0.1	0.11	-0.18	-0.05	0.41	0.04	-0.97	0.04	0.05	-0.14	0.14	-0.73
Free Cash Flow Yield	0.36	0.28	0.39	-0.08		0.4	-0.02	0.22	0.28	0.36	0.4	0.3	-0.37	0.11	0.08	0.0	0.5	0.17	-0.27	0.09	0.07	0.09	0.09	0.24	-0.56	0.17
Operating Cash Flow Per Share	-0.15	0.36	-0.12	0.82	0.4		0.55	0.25	0.36	-0.15	1.0	-0.04	-0.03	0.94	-0.12	0.18	0.03	0.08	0.12	0.15	-0.85	0.14	0.16	-0.07	-0.13	-0.49
Average Payables	-0.44	0.28	-0.38	0.66	-0.02	0.55		-0.06	0.28	-0.44	0.55	-0.33	-0.04	0.57	-0.02	0.08	-0.12	0.09	0.4	0.2	-0.62	0.17	0.2	-0.2	-0.11	-0.52
Capex To Depreciation	0.24	0.11	0.23	0.13	0.22	0.25	-0.06		0.11	0.24	0.25	0.22	-0.25	0.22	0.32	-0.32	0.38	0.41	-0.37	0.1	-0.1	0.06	0.11	0.2	-0.13	0.18
Pb Ratio	0.48	1.0	0.52	0.25	0.28	0.36	0.28	0.11		0.48	0.36	0.14	-0.28	0.34	0.38	-0.27	0.47	0.01	-0.27	0.8	-0.22	0.8	0.8	-0.03	-0.31	0.11
Ev To Sales	1.0	0.48	0.98	-0.25	0.36	-0.15	-0.44	0.24	0.48		-0.15	0.08	-0.46	-0.18	0.61	-0.6	0.73	0.09	-0.58	0.24	0.32	0.27	0.24	0.39	-0.21	0.42
Free Cash Flow Per Share	-0.15	0.36	-0.12	0.82	0.4	1.0	0.55	0.25	0.36	-0.15		-0.04	-0.03	0.94	-0.12	0.18	0.03	0.08	0.12	0.15	-0.85	0.14	0.16	-0.07	-0.13	-0.49
Roic	0.08	0.14	0.13	-0.41	0.3	-0.04	-0.33	0.22	0.14	0.08	-0.04		-0.08	-0.19	0.11	-0.06	0.27	-0.08	-0.47	0.22	0.36	0.2	0.22	0.17	-0.22	0.78
Inventory Turnover	-0.46	-0.28	-0.48	0.06	-0.37	-0.03	-0.04	-0.25	-0.28	-0.46	-0.03	-0.08		0.09	-0.79	0.71	-0.68	-0.3	0.35	-0.08	-0.26	-0.07	-0.09	-0.4	0.51	-0.35
Net Income Per Share	-0.18	0.34	-0.15	0.93	0.11	0.94	0.57	0.22	0.34	-0.18	0.94	-0.19	0.09		-0.08	0.1	-0.02	0.05	0.13	0.1	-0.96	0.09	0.11	-0.06	0.16	-0.57
Days Of Inventory On Hand	0.61	0.38	0.64	-0.1	0.08	-0.12	-0.02	0.32	0.38	0.61	-0.12	0.11	-0.79	-0.08		-0.98	0.85	0.35	-0.65	0.11	0.26	0.08	0.12	0.54	-0.08	0.53
Payables Turnover	-0.6	-0.27	-0.62	0.11	0.0	0.18	0.08	-0.32	-0.27	-0.6	0.18	-0.06	0.71	0.1	-0.98		-0.82	-0.37	0.67	0.01	-0.26	0.04	0.0	-0.62	-0.06	-0.52
Average Inventory	0.73	0.47	0.77	-0.18	0.5	0.03	-0.12	0.38	0.47	0.73	0.03	0.27	-0.68	-0.02	0.85	-0.82		0.39	-0.81	0.13	0.26	0.1	0.14	0.59	-0.14	0.59
Capex To Revenue	0.09	0.01	0.07	-0.05	0.17	0.08	0.09	0.41	0.01	0.09	0.08	-0.08	-0.3	0.05	0.35	-0.37	0.39		-0.41	0.01	0.06	-0.05	0.01	-0.02	-0.1	0.1
Cash Per Share	-0.58	-0.27	-0.6	0.41	-0.27	0.12	0.4	-0.37	-0.27	-0.58	0.12	-0.47	0.35	0.13	-0.65	0.67	-0.81	-0.41		-0.1	-0.38	-0.06	-0.11	-0.53	-0.1	-0.73
Pocfratio	0.24	0.8	0.21	0.04	0.09	0.15	0.2	0.1	0.8	0.24	0.15	0.22	-0.08	0.1	0.11	0.01	0.13	0.01	-0.1		-0.04	0.99	1.0	-0.3	-0.48	0.12
Interest Coverage	0.32	-0.22	0.3	-0.97	0.07	-0.85	-0.62	-0.1	-0.22	0.32	-0.85	0.36	-0.26	-0.96	0.26	-0.26	0.26	0.06	-0.38	-0.04		-0.04	-0.05	0.19	-0.23	0.75
Capex To Operating Cash Flow	0.27	0.8	0.24	0.04	0.09	0.14	0.17	0.06	0.8	0.27	0.14	0.2	-0.07	0.09	0.08	0.04	0.1	-0.05	-0.06	0.99	-0.04		0.99	-0.33	-0.5	0.1
Pfcf Ratio	0.24	0.8	0.22	0.05	0.09	0.16	0.2	0.11	0.8	0.24	0.16	0.22	-0.09	0.11	0.12	0.0	0.14	0.01	-0.11	1.0	-0.05	0.99		-0.29	-0.47	0.12
Days Payables Outstanding	0.39	-0.03	0.37	-0.14	0.24	-0.07	-0.2	0.2	-0.03	0.39	-0.07	0.17	-0.4	-0.06	0.54	-0.62	0.59	-0.02	-0.53	-0.3	0.19	-0.33	-0.29		0.22	0.41
Income Quality	-0.22	-0.31	-0.2	0.14	-0.56	-0.13	-0.11	-0.13	-0.31	-0.21	-0.13	-0.22	0.51	0.16	-0.08	-0.06	-0.14	-0.1	-0.1	-0.48	-0.23	-0.5	-0.47	0.22		-0.12
Roe	0.42	0.11	0.46	-0.73	0.17	-0.49	-0.52	0.18	0.11	0.42	-0.49	0.78	-0.35	-0.57	0.53	-0.52	0.59	0.1	-0.73	0.12	0.75	0.1	0.12	0.41	-0.12

Click cells to compare fundamentals

Assembly Biosciences Account Relationship Matchups

Assembly Biosciences fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	539.55	36.42	208.05	6.29	3.32	3.16
Ptb Ratio	11.97	7.7	0.76	1.1	2.84	2.7
Days Sales Outstanding	77.15	5.68	19.61	2.19	2.52	2.39
Book Value Per Share	6.06	3.63	20.49	8.98	5.56	5.83
Free Cash Flow Yield	(0.0226)	(0.0742)	(1.34)	0.5	(0.54)	(0.51)
Operating Cash Flow Per Share	(1.59)	(2.01)	(20.94)	4.97	(8.51)	(8.94)
Stock Based Compensation To Revenue	1.29	0.28	0.84	0.71	0.11	0.1
Capex To Depreciation	3.21	6.64	0.2	0.57	0.22	0.21
Pb Ratio	11.97	7.7	0.76	1.1	2.84	2.7
Ev To Sales	537.39	35.79	201.79	3.85	2.09	1.98
Free Cash Flow Per Share	(1.64)	(2.07)	(20.96)	4.91	(8.52)	(8.94)
Roic	(0.23)	(0.72)	(1.01)	(0.65)	(0.64)	(0.67)
Net Income Per Share	(1.5)	(2.79)	(22.82)	(13.38)	(6.69)	(7.03)
Payables Turnover	0.022	0.18	0.2	106.07	95.47	100.24
Sales General And Administrative To Revenue	2.06	0.47	4.6	3.2	0.63	0.6
Research And Ddevelopement To Revenue	5.37	1.35	10.96	6.83	1.96	1.86
Capex To Revenue	0.0974	0.0281	0.5	0.0356	9.82E-4	9.33E-4
Cash Per Share	5.45	3.15	22.71	28.45	18.67	17.28
Pocfratio	(45.76)	(13.93)	(0.75)	1.98	(1.85)	(1.76)
Capex To Operating Cash Flow	(0.0353)	(0.0331)	(0.001208)	0.0112	(5.48E-4)	(5.2E-4)
Pfcf Ratio	(44.2)	(13.48)	(0.74)	2.0	(1.85)	(1.76)
Days Payables Outstanding	16.6K	2.1K	1.8K	3.44	3.96	3.76
Roe	(0.25)	(0.77)	(1.11)	(1.49)	(1.2)	(1.26)
Ev To Operating Cash Flow	(44.97)	(13.51)	(0.17)	1.21	(1.16)	(1.11)
Pe Ratio	(48.39)	(10.02)	(0.68)	(0.74)	(2.36)	(2.48)
Return On Tangible Assets	(0.33)	(0.25)	(0.67)	(0.9)	(0.45)	(0.35)
Ev To Free Cash Flow	(43.44)	(13.08)	(0.17)	1.22	(1.16)	(1.11)
Earnings Yield	(0.0207)	(0.0998)	(1.46)	(1.36)	(0.42)	(0.45)
Intangibles To Total Assets	0.16	0.12	0.15	(0.008086)	(0.009299)	(0.008834)
Net Debt To E B I T D A	0.76	0.43	0.53	0.27	0.78	0.39
Current Ratio	9.19	9.59	5.95	3.41	2.42	2.3
Tangible Book Value Per Share	5.01	3.66	20.49	8.98	5.56	5.83
Receivables Turnover	4.73	64.31	18.61	166.58	149.92	157.42
Shareholders Equity Per Share	6.06	3.63	20.49	8.98	5.56	5.83
Debt To Equity	0.0421	0.0383	0.0419	0.057	0.0926	0.0972

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Assembly Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Assembly Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Assembly Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Assembly Biosciences Stock:

How To Invest In Assembly

Details

Is Assembly Stock a good investment?

Details

What is Assembly Biosciences' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.

You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assembly Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.69)

Revenue Per Share

4.75

Quarterly Revenue Growth

0.027

Return On Assets

(0.22)

Return On Equity

(1.08)

The market value of Assembly Biosciences is measured differently than its book value, which is the value of Assembly that is recorded on the company's balance sheet. Investors also form their own opinion of Assembly Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Assembly Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assembly Biosciences' market value can be influenced by many factors that don't directly affect Assembly Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Assembly Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assembly Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Short Term Coverage Ratios
Price Earnings Ratio	Operating Cycle
Price Book Value Ratio	Price Earnings To Growth Ratio
Days Of Payables Outstanding	Dividend Payout Ratio
Price To Operating Cash Flows Ratio	Price To Free Cash Flows Ratio
Pretax Profit Margin	Ebt Per Ebit
Operating Profit Margin	Effective Tax Rate
Company Equity Multiplier	Long Term Debt To Capitalization
Total Debt To Capitalization	Return On Capital Employed
Debt Equity Ratio	Ebit Per Revenue
Quick Ratio	Dividend Paid And Capex Coverage Ratio
Net Income Per E B T	Cash Ratio
Cash Conversion Cycle	Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding	Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio	Cash Flow Coverage Ratios
Price To Book Ratio	Fixed Asset Turnover
Capital Expenditure Coverage Ratio	Price Cash Flow Ratio
Enterprise Value Multiple	Debt Ratio
Cash Flow To Debt Ratio	Price Sales Ratio
Return On Assets	Asset Turnover
Net Profit Margin	Gross Profit Margin
Price Fair Value	Return On Equity

Assembly Historical Financial Ratios

About Assembly Financial Ratios Analysis

Assembly Biosciences Financial Ratios Chart

Price To Sales Ratio

Average Payables

Ev To Sales

Assembly Biosciences fundamentals Correlations

Assembly Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Assembly Biosciences fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Free Cash Flow Per Share	+ 1.0	Operating Cash Flow Per Share
Pfcf Ratio	+ 1.0	Pocfratio
Capex To Operating Cash Flow	+ 0.99	Pocfratio
Pfcf Ratio	+ 0.99	Capex To Operating Cash Flow

Payables Turnover	- 0.98	Days Of Inventory On Hand
Interest Coverage	- 0.97	Book Value Per Share
Interest Coverage	- 0.96	Net Income Per Share
Interest Coverage	- 0.85	Free Cash Flow Per Share
Interest Coverage	- 0.85	Operating Cash Flow Per Share
Average Inventory	- 0.82	Payables Turnover